Archie from United Kingdom

Registered at the short selling broker NS Broker, 3 minutes ago.

» Try NS Broker you too
54.6% of retail CFD accounts lose money.
Don't show again

Prometheus Biosciences Inc (RXDX) shares information

Prometheus Biosciences Inc


24h Change

-4.69 %

RXDX

Live rate: Market closed

Stock data per Friday 21 Jan, 2022

RXDX
NASDAQ
34.14
33.73
32.54
-1.6 (-4.69%)
US Market is closed

Live Stock price in graph for Prometheus Biosciences Inc (RXDX)

  • Latest Volume

    230,696 (2.3 %)

  • Volume prev. day

    225,512

  • Avg. daily volume

    192,083

  • Market cap

    1,267,082,219

  • P/E ratio

    n/a

  • Today high

    35 USD

  • Today low

    32.1 USD

  • 52 week high

    40.49 USD

  • 52 week low

    16.11 USD

  • YTD Change

    n/a

Quick links

 

Latest news about Prometheus Biosciences Inc

Below you can find the most recent news posts about Prometheus Biosciences Inc, primarily from US and UK based news sources.

Prometheus Biosciences Inc Shares Close the Day 17.1% Higher – Daily Wrap

Sunday, 16 January 2022, 21:28:50
Prometheus Biosciences Inc (RXDX) shares closed today 17.1% higher than it did at the end of yesterday. The stock is currently down 10.7% year-to-date, up 39.5% over the past 12 months, and up 39.5% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $36.87 and as low as $29.50 this week.Shares closed 12.8% below its 52-week high and 119.1% above its 52-week low.Trading volume this week was 28.5% higher than the 10-day average and 76.3% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance The company's share price beats the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 103.4% The company's stock price performance over the past 12 months beats the peer average by -233.7%

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected] © 2020 Kwhen Inc.


— Kwhen Finance


Prometheus Biosciences Inc Shares Close the Day 17.1% Higher – Daily Wrap

Saturday, 15 January 2022, 18:41:12
Prometheus Biosciences Inc (RXDX) shares closed today 17.1% higher than it did at the end of yesterday. The stock is currently down 10.7% year-to-date, up 39.5% over the past 12 months, and up 39.5% over the past five years. Today, the Dow Jones Industrial Average fell 0.6%, and the S&P 500 rose 0.0%. Trading Activity Shares traded as high as $36.87 and as low as $29.50 this week.Shares closed 12.8% below its 52-week high and 119.1% above its 52-week low.Trading volume this week was 43.4% higher than the 10-day average and 1.3% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought.The stock closed at 8.6% higher than its 5-day moving average, 0.6% lower than its 20-day moving average, and 15.4% higher than its 90-day moving average.
Market Comparative Performance The company's share price beats the S&P 500 Index today, beats it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, beats it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 115.7% The company's stock price performance over the past 12 months beats the peer average by -229.3%

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected] © 2020 Kwhen Inc.


— Kwhen Finance


Prometheus Biosciences Inc Shares Close the Day 10.7% Higher – Daily Wrap

Tuesday, 21 December 2021, 02:08:18
Prometheus Biosciences Inc (RXDX) shares closed today 10.7% higher than it did at the end of yesterday. The stock is currently up 17.9% year-to-date, up 17.9% over the past 12 months, and up 17.9% over the past five years. Today, the Dow Jones Industrial Average fell 1.2%, and the S&P 500 fell 1.1%. Trading Activity Shares traded as high as $35.47 and as low as $28.74 this week.Shares closed 17.5% below its 52-week high and 104.8% above its 52-week low.Trading volume this week was 234.4% higher than the 10-day average and 560.8% higher than the 30-day average.Beta, a measure of the stock’s volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by -198.9% The company's stock price performance over the past 12 months beats the peer average by -176.6%

This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected] © 2020 Kwhen Inc.


— Kwhen Finance


Prometheus Biosciences (NASDAQ:RXDX) Now Covered by Analysts at Wells Fargo & Company

Saturday, 11 December 2021, 11:18:44
Wells Fargo & Company initiated coverage on shares of Prometheus Biosciences (NASDAQ:RXDX) in a report released on Wednesday morning, Price Targets.com reports. The brokerage issued an overweight rating and a $42.00 price objective on the biopharmaceutical companys stock. Other equities analysts also recently issued reports about the stock. SVB Leerink upped their target price on []
— Transcript Daily


Prometheus Biosciences (NASDAQ:RXDX) Receives New Coverage from Analysts at Wells Fargo & Company

Thursday, 9 December 2021, 11:50:43
Wells Fargo & Company started coverage on shares of Prometheus Biosciences (NASDAQ:RXDX) in a research report sent to investors on Wednesday morning, Analyst Ratings Network reports. The firm issued an overweight rating and a $42.00 target price on the biopharmaceutical companys stock. Several other research analysts also recently commented on RXDX. SVB Leerink lifted their []
— Dakota Financial News


Trading broker recommendation

We recommend that you check out Capital.com as they have a very good selection of stocks available for both going short and long.

Rating: 9.57/10
Minimum deposit: €250 by bank
Description: Capital.com offer a large number of stocks for trading. Register an account today and check if they have RXDX available or trade one of the many other CFD stocks they have.
Risk warning: 67.7% of retail investor accounts lose money when trading CFDs with Capital.